CA-L12 -60 Capsules

60 Capsules Small

500mg /capsule

Price : 380 $ USD

Another size

45 Capsules Big

775mg / capsule

Price : 427 $ USD

Composition :

Urtica dioica / roots
Pimpinella anisum / seeds
Viscum album / whole plant
Pinus sylvestris / flowers and leaves
Mentha piperita / leaves
Viola odorata / flowers
Glycyrrhiza glabra / roots
Foeniculum vulgare / fruits
Malva sylvestris / flowers

CAL 12 :

A third-generation herbal medicine made from natural medicinal plants, with no side effects. It is used as an adjuvant treatment for respiratory system tumors and cancers, as well as for difficult-to-treat respiratory diseases.

Indications :

– Benign or malignant lung tumors.
– Breast cancer.
– Cancers of the upper aero-digestive tract.
– Throat cancer.
– Croup (laryngotracheobronchitis).
– Respiratory failure due to muscular respiratory disease.
– Hemothorax (blood accumulation in the pleural cavity).
– Interstitial lung disease (destruction of alveolar lining cells).
– Pulmonary emphysema (alveolar wall destruction).
– Goodpasture syndrome and glomerulonephritis (recurrent pulmonary hemorrhage).
– Pulmonary edema (fluid accumulation in the lungs).
– Pulmonary embolism.
– Bronchopulmonary dysplasia.
– Cystic fibrosis (mucoviscidosis).
– Sarcoidosis.
– Idiopathic pulmonary fibrosis.
– Laryngeal or pleural tuberculosis.
– Severe acute respiratory syndrome (SARS).
– Pulmonary fungal infections.
– Pleurisy.
– Pneumonia.
– Lung abscess.
– Hantavirus pulmonary syndrome.
– Pulmonary hypertension.
– Lymphangioleiomyomatosis (LAM): progressive cystic lung destruction with lymphatic abnormalities.
– Bronchiectasis (damaged bronchi).
– COPD (chronic obstructive pulmonary disease).
– Pleural emphysema (formation of fibrotic partitions around the lung).

CAL 12 Benefits :

– Stimulates and strengthens the immune system to fight respiratory tumors.
– Targets cancer cells, promotes genetic repair or induces apoptosis if not repairable.
– Activates anti-tumor exosome activity.
– Hinders molecular signaling pathways between tumor cells and their microenvironment, thereby reducing the initiation of carcinogenic processes in healthy cells.
– Stimulates Gamma Interferon (IKDC – Interferon-producing killer dendritic cells), boosting the immune response and inhibiting tumor angiogenesis (formation of new blood vessels feeding the tumor).
– Triggers phagocytic immune responses against tumors.
– Balances the production of T-KILLER cells within the adaptive immune response.
– Potentiates phagocytosis and facilitates antigenic recognition of mutated tumor cells by T lymphocytes.
– Activates cytotoxic T lymphocytes and regulates immune checkpoint molecules. This activation causes a rise in internal body temperature (by about 1°C), which supports cellular latency and eventually triggers apoptosis.